<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26964" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pericholangitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amini</surname>
            <given-names>Afshin</given-names>
          </name>
          <aff>St. Luke's Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nagalli</surname>
            <given-names>Shivaraj</given-names>
          </name>
          <aff>Yuma Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Afshin Amini declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shivaraj Nagalli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26964.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The diagnostic criteria for small-duct primary sclerosing cholangitis (SDPSC) included biochemical features of chronic cholestasis with unknown etiology, normal cholangiogram, liver histology compatible with PSC. SDPSC is more common in males with an average age of 38 years old. This activity reviews the evaluation and management of SDPSC and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the small duct primary sclerosing cholangitis in the etiology of chronic cholestasis.</p></list-item><list-item><p>Describe the pathophysiology of small duct primary sclerosing cholangitis.</p></list-item><list-item><p>Summarize the prognosis of small duct primary sclerosing cholangitis compares to large duct primary sclerosing cholangitis.</p></list-item><list-item><p>Explain the importance of SDPSC diagnosis and how it affects to improving care coordination among the interprofessional team when distinguishing SDPSC from large duct primary sclerosing cholangitis (LDPSC).</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26964&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26964">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26964.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Primary sclerosing cholangitis (PSC) is an uncommon cholestatic liver disease characterized by the inflammation and fibrosis of intra- and extra-hepatic biliary ducts. It has an incidence of 0.9 to 1.3 cases per 100000 in the United States.<xref ref-type="bibr" rid="article-26964.r1">[1]</xref>&#x000a0;After recruiting of endoscopic retrograde cholangiopancreatography (ERCP) in the early 1970s, it revealed that &#x02018;classical&#x02019; primary sclerosing cholangitis (PSC) appears as multiple strictures in the intra- and extra-hepatic biliary tree.<xref ref-type="bibr" rid="article-26964.r2">[2]</xref>&#x000a0;However, the ERCP is not diagnostic for the detection of the small intra-hepatic biliary strictures.<xref ref-type="bibr" rid="article-26964.r3">[3]</xref>&#x000a0;Then, in 1985, this question raised by Ludwig that whether the small bile ducts might be involved in PSC.<xref ref-type="bibr" rid="article-26964.r4">[4]</xref>&#x000a0;Pathological studies in 1991 led to the coining of the term small duct PSC (SDPSC).&#x000a0;<xref ref-type="bibr" rid="article-26964.r5">[5]</xref>&#x000a0;Later, SDPSC was defined in the patients with inflammatory bowel disease and chronic cholestasis, who have normal cholangiogram with liver biopsy diagnostic for PSC.<xref ref-type="bibr" rid="article-26964.r6">[6]</xref></p>
      </sec>
      <sec id="article-26964.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of small duct primary sclerosing cholangitis (SDPSC), also referred to as 'pericholangitis,' is unknown. However, with consideration of SDPSC as a subtype of PSC, dietary exposure, infection, toxins, and autoimmunity can be the initial insults.<xref ref-type="bibr" rid="article-26964.r7">[7]</xref>&#x000a0;Naess et al. investigated the genetic association between the patients of SDPSC and LDPSC. They concluded HLA-DRB1*13:01 and B*08 alleles were significantly associated with SDPSC. Also, SDPSC, when associated with IBD, is genetically similar to LDPSC and represent milder version or early stages of LDPSC. However, when SDPSC does not&#x000a0;correlate with IBD, they were genetically dissimilar to LDPSC.<xref ref-type="bibr" rid="article-26964.r8">[8]</xref></p>
      </sec>
      <sec id="article-26964.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The male predominance observed in large duct pathology was confirmed in the small duct patients with inflammatory bowel disease, although not in the group of patients without IBD, where females predominated.<xref ref-type="bibr" rid="article-26964.r9">[9]</xref>&#x000a0;A study by Bjornsson et al. on 83 patients with small-duct PSC showed 51 males (61.5%) and 32 females (38.5%). This study reported the median age at the time of small duct PSC diagnosis was 38 years. It reported no significant ethnicity consistency.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;In a study by Singal et al. on 25 patients with SDPSC, the mean age of diagnosing was 37 years old, with a male to female ratio of 13:12.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref>&#x000a0;The study by&#x000a0;Charatcharoenwitthaya et al. on forty-two patients with SDPSC was confirmed the male dominance.<xref ref-type="bibr" rid="article-26964.r12">[12]</xref>&#x000a0;Heikius et al., in a Finnish study, evaluated the prevalence of SDPSC in IBD patients. After studying 237 unselected patients with IBD, they reported the prevalence of PSC was 11%. Of these patients, 11.5% had the small-duct variant.<xref ref-type="bibr" rid="article-26964.r13">[13]</xref>&#x000a0;Among adults with PSC, 75% have involvement of both small and large ducts, 15% small ducts only, and 10% large ducts only. Small duct PSC typically presents with an insidious onset of symptoms or with end-stage liver disease.<xref ref-type="bibr" rid="article-26964.r7">[7]</xref></p>
      </sec>
      <sec id="article-26964.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Small duct PSC is considered as a subtype of PSC. Generally, PSC divides into four subgroups due to similarity:</p>
        <list list-type="order">
          <list-item>
            <p>Classic PSC (intrahepatic and extrahepatic strictures on cholangiography)</p>
          </list-item>
          <list-item>
            <p>Intrahepatic PSC (intrahepatic strictures on cholangiography)</p>
          </list-item>
          <list-item>
            <p>Extrahepatic PSC (extrahepatic stricture on cholangiography)</p>
          </list-item>
          <list-item>
            <p>Small duct PSC (normal on cholangiography).<xref ref-type="bibr" rid="article-26964.r14">[14]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>The role of immune-mediated mechanisms in the PSC patients has support from the association of human leukocyte antigen (HLA) and non-HLA haplotypes, and the presence of autoantibodies in serology.<xref ref-type="bibr" rid="article-26964.r15">[15]</xref>&#x000a0;Also, the association between IBD and PSC can be explained by different hypotheses. The leaky gut hypothesis described<italic toggle="yes">&#x000a0;</italic>bacteria or bacterial components and products passing the inflame bowel wall and enter the portal venous system, which results in concomitant initiation of an inflammatory reaction focused on portal fields.<xref ref-type="bibr" rid="article-26964.r16">[16]</xref>&#x000a0;The gut lymphocyte homing hypothesis arose to justify the association of PSC in inactive IBD patients. This hypothesis assumes&#x000a0;that CCR9+ &#x003b1;4&#x003b2;7+ memory T lymphocytes primed persist in the inflamed gut and entering into an enterohepatic circulation, which can be the trigger for portal inflammation in PSC through abnormally expressed adhesion molecules in the gut and liver.<xref ref-type="bibr" rid="article-26964.r17">[17]</xref></p>
      </sec>
      <sec id="article-26964.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Except for extrahepatic PSC, LDPSC, SDPSC, and intrahepatic PSC have similar liver histology features, described as nonsuppurative cholangitis, periductal fibrosis, ductular reaction, and ductopenia. However, in extrahepatic PSC, the histology features are nondiagnostic or nonspecific features of cholestasis, particularly in early-stage disease.<xref ref-type="bibr" rid="article-26964.r14">[14]</xref>&#x000a0;Liver Biopsy findings classically reported as an &#x0201c;onion skin&#x0201d; appearance, which includes non-suppurative cholangitis, ductular reaction, ductopenia, and periductal fibrosis. However, this classic finding is present in almost 10% of liver biopsies. Furthermore, histology alone is not enough for making the diagnosis of PSC.<xref ref-type="bibr" rid="article-26964.r18">[18]</xref>&#x000a0;Other diseases such as IgG4-associated cholangiopathy, ductopenic rejection following a liver transplant, and acquired immune deficiency syndrome&#x000a0;also can have similar histopathology, which seen in PSC.<xref ref-type="bibr" rid="article-26964.r19">[19]</xref>&#x000a0;The main reason for liver biopsy in large-duct PSC patients is to exclude other diseases, determine the stage of PSC, and diagnose small-duct PSC.<xref ref-type="bibr" rid="article-26964.r20">[20]</xref></p>
      </sec>
      <sec id="article-26964.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The specific diagnostic criteria in small duct PSC are still challenging, particularly whether the existence of IBD is a requirement for the diagnosis or not. The detail definition has varied from study to study. Generally, IBD is not a mandatory criterion for small duct PSC.<xref ref-type="bibr" rid="article-26964.r21">[21]</xref> The diagnostic criteria for small-duct PSC included biochemical features of chronic cholestasis with unknown etiology, normal cholangiogram, liver histology compatible with PSC.<xref ref-type="bibr" rid="article-26964.r22">[22]</xref> The diagnosis criteria for large-duct PSC are the same as small-duct PSC, except for the findings of bile duct strictures and dilations (&#x0201c;string of beads&#x0201d;), which are the typical features of LDPSC.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;Data from the studies showed that abnormal liver biochemistries are the most common cause of presentation. However, clinical symptoms or signs are not uncommon with abdominal pain, fatigue, pruritus, and weight loss are the most common presentations.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref><xref ref-type="bibr" rid="article-26964.r23">[23]</xref>&#x000a0;The data from Bjornsson et al. revealed a strong correlation between small duct PSC and IBD. From the 83 patients with small duct PSC, approximately 81% of patients had colitis which is including ulcerative colitis (78%), Crohn&#x02019;s colitis (21%), and collagenous colitis (1%).&#x000a0;However, this study concluded there is no difference existing in the outcome (defined as died or underwent liver transplantation) between small duct PSC either with ulcerative colitis or with Crohn&#x02019;s colitis.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;Also, it seems that Crohn&#x02019;s colitis related to small-duct PSC more than large-duct PSC.<xref ref-type="bibr" rid="article-26964.r24">[24]</xref></p>
      </sec>
      <sec id="article-26964.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p><bold>Laboratory tests</bold><bold>&#x000a0;</bold>- In most patients, liver biochemical tests usually show elevation of the serum alkaline phosphatase. The serum aminotransferases are generally less than 300 international unit/L. The serum albumin concentration may be low in patients with active inflammatory bowel disease, although in early-stage PSC is often normal.<xref ref-type="bibr" rid="article-26964.r25">[25]</xref>&#x000a0;Elevation of serum immunoglobulin G4 (IgG4), which is a marker of autoimmune pancreatitis, has been reported in patients with PSC.<xref ref-type="bibr" rid="article-26964.r26">[26]</xref><xref ref-type="bibr" rid="article-26964.r27">[27]</xref><xref ref-type="bibr" rid="article-26964.r26">[26]</xref>&#x000a0;Other known etiology of chronic cholestasis require exclusion by appropriate laboratory tests, clinical evaluation, imaging, and histologic criteria. The following etiologies, such as autoimmune hepatitis, primary biliary cirrhosis (PBC), drug-induced liver disease, chronic viral liver disease, alcoholic hepatitis, and HIV infection, should rule out by laboratory tests and history. Furthermore, pancreatic disease and gall stone should exclude by ultrasound examination.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
        <p><bold>Cholangiography&#x000a0;</bold>- It is helpful for the evaluation of affected biliary radicles&#x000a0;greater than 100 micro millimeters. Various options such as Endoscopic retrograde cholangiopancreatography (ERCP), magnetic resonance cholangiopancreatography (MRCP),&#x000a0;or percutaneous transhepatic cholangiography (PTC) are available to obtain cholangiograms. However, being noninvasive and accurate makes MRCP as the preferred test of choice to distinguish SDPSC from LDPSC.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref><xref ref-type="bibr" rid="article-26964.r28">[28]</xref><xref ref-type="bibr" rid="article-26964.r29">[29]</xref><xref ref-type="bibr" rid="article-26964.r30">[30]</xref>&#x000a0;Small duct primary sclerosing cholangitis involves biliary calibers less than 100 micro millimeters, which lead to normal cholangiogram.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref>&#x000a0;However, cumulative follow-up data by Bjornsson et al. reported that nineteen (22.9%) of SDPSC progress to large duct PSC after a median of 7.4 years.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
        <p><bold>Liver biopsy -&#x000a0;</bold>The most specific histologic finding in SDPSC is the "onion skin" pattern, which describes as fibrous obliteration and concentric replacement of connective tissue in small bile ducts.<xref ref-type="bibr" rid="article-26964.r20">[20]</xref>&#x000a0;Although, this classic finding histology alone is not enough for making a diagnosis of SDPSC.<xref ref-type="bibr" rid="article-26964.r18">[18]</xref></p>
        <p><bold>Liver ultrasound&#x000a0;</bold>-&#x000a0;Ultrasound findings are commonly used to rule out a secondary cause of chronic cholestasis, such as pancreatic disease and gallbladder abnormalities.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
      </sec>
      <sec id="article-26964.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are no reported data in the literature regarding specific treatment for SDPSC. Charatcharoenwitthaya et al. .evalute the effect of ursodeoxycholic&#x000a0;acid&#x000a0;(UDCA) in 42 patients with SDPSC and follow the liver disease progression (cirrhosis, liver transplantation) and liver biochemistries for 24.9 years. They reported UDCA therapy might not delay disease progression but improves the liver biochemistries.<xref ref-type="bibr" rid="article-26964.r12">[12]</xref>&#x000a0;However, liver transplant in SDPSC patients who present with end-stage liver disease has longer transplantation-free survival than large duct PSC (13 years vs. ten years, respectively).<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
      </sec>
      <sec id="article-26964.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Intrinsic or Extrinsic Compressive Causes (Either Benign or Malignant)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Cholangiocarcinoma</p>
          </list-item>
          <list-item>
            <p>Mirizzi syndrome</p>
          </list-item>
          <list-item>
            <p>Compressive lymphadenopathy</p>
          </list-item>
          <list-item>
            <p>Portal hypertensive biliopathy</p>
          </list-item>
          <list-item>
            <p>Diffuse intrahepatic malignancy</p>
          </list-item>
          <list-item>
            <p>Postoperative strictures</p>
          </list-item>
          <list-item>
            <p>Chronic pancreatitis</p>
          </list-item>
        </list>
        <p>
<bold>Infectious Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>AIDS cholangiopathy (e.g.,&#x000a0;<italic toggle="yes">Cryptosporidium parvum</italic>, cytomegalovirus)</p>
          </list-item>
          <list-item>
            <p>Recurrent pyogenic cholangitis (also known as oriental cholangio-hepatitis)</p>
          </list-item>
          <list-item>
            <p>Helminthic infection (e.g.,&#x000a0;<italic toggle="yes">Clonorchis, Opisthorchis, Ascaris</italic>)</p>
          </list-item>
        </list>
        <p>
<bold>Ischemic Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Posttransplant non-anastomotic strictures</p>
          </list-item>
          <list-item>
            <p>Postintraarterial chemotherapy</p>
          </list-item>
          <list-item>
            <p>Postradiation therapy</p>
          </list-item>
        </list>
        <p>
<bold>Immunologic Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG4-associated cholangiopathy</p>
          </list-item>
          <list-item>
            <p>Eosinophilic cholangitis</p>
          </list-item>
          <list-item>
            <p>Mast cell cholangiopathy</p>
          </list-item>
          <list-item>
            <p>Histiocytosis X</p>
          </list-item>
          <list-item>
            <p>Systemic vasculitis</p>
          </list-item>
          <list-item>
            <p>Hepatic allograft rejection</p>
          </list-item>
          <list-item>
            <p>Primary biliary cholangitis</p>
          </list-item>
        </list>
        <p>
<bold>Congenital and/or Idiopathic Causes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Choledochal cysts (e.g., Caroli disease)</p>
          </list-item>
          <list-item>
            <p>Progressive familial intrahepatic cholestasis&#x000a0;<xref ref-type="bibr" rid="article-26964.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26964.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In contrast to patients with large duct PSC, Small duct PSC has had less research, and usually, the studies compare its prognosis with large duct PSC. Large duct PSC is associated with progression of fibrosis to cirrhosis, end-stage liver disease, and liver transplantation. These patients have an elevated risk of malignancy, particularly cholangiocarcinoma, hepatocellular carcinoma, and colorectal dysplasia and adenocarcinoma in the presence of IBD.<xref ref-type="bibr" rid="article-26964.r31">[31]</xref>&#x000a0;Colorectal cancer (CRC) in PSC patients with IBD is approximately a 5-fold higher compared to IBD alone.<xref ref-type="bibr" rid="article-26964.r32">[32]</xref> The most threatening neoplastic complication of PSC is cholangiocarcinoma, which was an estimated annual incidence of 1% and a lifetime occurrence of 15% in patients with PSC.<xref ref-type="bibr" rid="article-26964.r33">[33]</xref></p>
        <p>Small duct PSC, compared to large duct PSC, seems to be more benign. The results of the study by Bjornsson et al. presented the natural history of 33 patients with small duct PSC and 260 patients with large duct PSC over a mean follow-up of approximately nine years. In this study, only 4 (12%) of the 33 patients with small duct PSC died or required liver transplantation versus 122 (47%) of the 260 patients with large duct PSC.<xref ref-type="bibr" rid="article-26964.r22">[22]</xref>&#x000a0;The Mayo Clinic's study has confirmed these findings. In this study, Angulo et al. found that the median survival without liver transplantation was 29.5 years in patients with small duct PSC (n = 18) versus only 17 years in the large duct PSC group (n = 36). Survival in the small duct PSC group was similar to that expected in the white US population; however, the large duct PSC group was lower.<xref ref-type="bibr" rid="article-26964.r23">[23]</xref></p>
        <p>A minority of patients with small duct PSC eventually develop cholangiographic evidence of large-duct PSC. In the Bjornsson et al. study, cholangiography was repeated in 19 (58%) of the 33 patients with SDPSC. Only four patients (12%) developed large-duct PSC, with typical intrahepatic and/or extrahepatic changes on cholangiography.<xref ref-type="bibr" rid="article-26964.r22">[22]</xref>&#x000a0;In the Angula et al. study, 5 of the 18 patients with SDPSC underwent repeat cholangiography because of worsening liver biochemistry. Of these patients, 3 (17% of the total) developed typical cholangiographic features of large-duct PSC.<xref ref-type="bibr" rid="article-26964.r23">[23]</xref>&#x000a0;The study by Broom et al.,4 out of 32(12%) patients developed features of large duct PSC after a median time of 72 months. Two of the four patients had only intrahepatic changes, and one of them had developed cirrhosis. In the other two, the cholangiogram was compatible with intra- and extrahepatic biliary tree involvement.<xref ref-type="bibr" rid="article-26964.r9">[9]</xref></p>
        <p>Cumulative follow-up data by Bjornsson et al. reported that nineteen (22.9%) of SDPSC progress to large duct PSC after a median of 7.4 years. In this study, no progression to cholangiocarcinoma was reported except one patient who first developed to large duct PSC. Also, they indicated small duct PSC has longer transplantation-free survival than large -duct PSC(13 years vs. ten years, respectively). SDPSC&#x000a0;recured in two patients after liver transplantation.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;Singal et al. were revealed the data in 25 patients with SDPSC after 17 months of follow up. They did not report malignancy or progression to large duct PSC after the follow-up. However, Two patients developed to end-stage liver disease. One of these two underwent a liver transplant, and the other one with long-standing severe ulcerative colitis died due to sepsis before it could be transplanted.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref></p>
        <p>Charatcharoenwitthaya et al. reported that patients with concomitant of SDPSC and IBD have a better prognosis compare to SDPSC without IBD. Also, they concluded IBD associated with SDPSC had a lower prevalence of pancolitis compared to IBD in patients with large-duct PSC.<xref ref-type="bibr" rid="article-26964.r12">[12]</xref></p>
      </sec>
      <sec id="article-26964.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Progression to LDPSC, then possibly increased risk of cholangiocarcinoma.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;In contrast to LDPSC, there was no reported cholangiocarcinoma in isolated SDPSC.</p>
          </list-item>
          <list-item>
            <p>Fat-soluble vitamin deficiencies (A, D, E, and K)<xref ref-type="bibr" rid="article-26964.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Metabolic bone disease(osteopenia/osteoporosis rather than osteomalacia)<xref ref-type="bibr" rid="article-26964.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Liver cirrhosis and portal hypertension<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatocellular carcinoma in patients with cirrhosis<xref ref-type="bibr" rid="article-26964.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Recurrence after liver transplant<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26964.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Small duct primary sclerosing cholangitis (SDPSC) is a chronic cholestatic disorder described by inflammation and fibrosis of biliary calibers &#x0003c;100 micro millimeters.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref>&#x000a0;SDPSC is a rare disease with an unclear prevalence due to limited studies. SDPSC commonly affects males with a median age at diagnosis of 38 years. There is a significant association(81%) with inflammatory bowel disease.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref></p>
        <p>Most patients do not have any symptoms and usually detect by abnormal liver tests. However, in symptomatic patients, abdominal pain, fatigue, pruritus, and weight loss are the most common complaints.<xref ref-type="bibr" rid="article-26964.r11">[11]</xref>&#x000a0;For diagnosis of SDPSC, patients need to have abnormal liver enzyme tests with unknown etiology, normal cholangiogram, liver biopsy(histology compatible with PSC).<xref ref-type="bibr" rid="article-26964.r22">[22]</xref>&#x000a0;The prognosis of SDPSC is less clear than the large duct PSC. However, studies suggested better prognosis in terms of longer liver&#x000a0;transplantation-free survival.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;IBD (inflammatory bowel disease), fat-soluble vitamin deficiencies (A, D, E, and K), metabolic bone disease (osteopenia/osteoporosis rather than osteomalacia),&#x000a0;liver cirrhosis, hepatocellular carcinoma in patients with cirrhosis, and recurrence after liver transplant&#x000a0;are the most common complications reported in the literature.<xref ref-type="bibr" rid="article-26964.r35">[35]</xref><xref ref-type="bibr" rid="article-26964.r10">[10]</xref><xref ref-type="bibr" rid="article-26964.r9">[9]</xref>&#x000a0;No specific treatment is available for SDPSC. One study reported ursodeoxycholic&#x000a0;acid&#x000a0;(UDCA) therapy may not delay disease progression but can improve the liver biochemistries.<xref ref-type="bibr" rid="article-26964.r12">[12]</xref></p>
      </sec>
      <sec id="article-26964.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Small duct primary sclerosing cholangitis (SDPSC) is a rare disease with an unclear prevalence due to limited studies. The rarity of SDPSC causes challenges in diagnosis. The diagnostic criteria for small-duct PSC included biochemical features of chronic cholestasis with unknown etiology, normal cholangiogram, liver histology compatible with PSC.So, health professionals should be aware of etiologies that can cause abnormal liver enzymes and try to rule out them by choosing the correct laboratory or imaging tests. After excluding known causes of chronic cholestasis, patients should evaluate by cholangiogram (MRCP preferred) and liver biopsy to distinguish SDPSC from LDPSC. The study by Bjornsson et al. revealed the difference in prognosis between SDPSC and LDPSC. They concluded SDPSC has longer transplantation-free survival than LDPSC (13 years vs. ten years, respectively). Also, in this study, cholangiocarcinoma did not occur in SDPSC patients except one patient who already progressed to LDPSC.SDPSC can recur even after liver transplantation.<xref ref-type="bibr" rid="article-26964.r10">[10]</xref>&#x000a0;[Level3]</p>
        <p>In terms of improving outcomes and treatments, no data is available. Only one study evaluated the effect of ursodeoxycholic&#x000a0;acid&#x000a0;(UDCA) in SDPSC patients which did not show the delay in the progression of the disease, despite improvement in liver enzymes.<xref ref-type="bibr" rid="article-26964.r12">[12]</xref></p>
      </sec>
      <sec id="article-26964.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26964&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26964">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/pericholangitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26964">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26964/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26964">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26964.s16">
        <title>References</title>
        <ref id="article-26964.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bambha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Talwalkar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torgerson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Therneau</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Loftus</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Yawn</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Melton</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.</article-title>
            <source>Gastroenterology</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>1364</fpage>
            <page-range>1364-9</page-range>
            <pub-id pub-id-type="pmid">14598252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Arborgh</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Summerfield</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scheuer</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Sherlock</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.</article-title>
            <source>Gut</source>
            <year>1980</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>870</fpage>
            <page-range>870-7</page-range>
            <pub-id pub-id-type="pmid">7439807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Variant forms of cholestatic diseases involving small bile ducts in adults.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2000</year>
            <month>May</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>1130</fpage>
            <page-range>1130-8</page-range>
            <pub-id pub-id-type="pmid">10811317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?</article-title>
            <source>Ann Intern Med</source>
            <year>1985</year>
            <month>May</month>
            <volume>102</volume>
            <issue>5</issue>
            <fpage>581</fpage>
            <page-range>581-7</page-range>
            <pub-id pub-id-type="pmid">3985511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludwig</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Small-duct primary sclerosing cholangitis.</article-title>
            <source>Semin Liver Dis</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-7</page-range>
            <pub-id pub-id-type="pmid">2047885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis.</article-title>
            <source>Hepatology</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>325</fpage>
            <page-range>325-32</page-range>
            <pub-id pub-id-type="pmid">10385674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>LaRusso</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Shneider</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gores</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Doo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hoofnagle</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis: summary of a workshop.</article-title>
            <source>Hepatology</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>44</volume>
            <issue>3</issue>
            <fpage>746</fpage>
            <page-range>746-64</page-range>
            <pub-id pub-id-type="pmid">16941705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naess</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bj&#x000f6;rnsson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Anmarkrud</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Al Mamari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Juran</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Lazaridis</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bergquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Melum</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Schrumpf</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lie</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Boberg</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Karlsen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Hov</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.</article-title>
            <source>Liver Int</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>10</issue>
            <fpage>1488</fpage>
            <page-range>1488-95</page-range>
            <pub-id pub-id-type="pmid">24517468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broom&#x000e9;</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Glaumann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lindst&#x000f6;m</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>L&#x000f6;&#x000f6;f</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Almer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prytz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sandberg-Gertz&#x000e9;n</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fork</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>J&#x000e4;rnerot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).</article-title>
            <source>J Hepatol</source>
            <year>2002</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>586</fpage>
            <page-range>586-9</page-range>
            <pub-id pub-id-type="pmid">11983440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bj&#x000f6;rnsson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bergquist</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lindgren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Braden</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Boberg</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The natural history of small-duct primary sclerosing cholangitis.</article-title>
            <source>Gastroenterology</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>134</volume>
            <issue>4</issue>
            <fpage>975</fpage>
            <page-range>975-80</page-range>
            <pub-id pub-id-type="pmid">18395078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singal</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Stanca</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Odin</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fiel</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Bach</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.</article-title>
            <source>Hepatol Int</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>808</fpage>
            <page-range>808-13</page-range>
            <pub-id pub-id-type="pmid">21484124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charatcharoenwitthaya</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enders</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.</article-title>
            <source>Hepatology</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>133</fpage>
            <page-range>133-42</page-range>
            <pub-id pub-id-type="pmid">17992695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heikius</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Niemel&#x000e4;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lehtola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Karttunen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000e4;hde</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-61</page-range>
            <pub-id pub-id-type="pmid">9051876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tabibian</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.</article-title>
            <source>Gastroenterol Hepatol (N Y)</source>
            <year>2018</year>
            <month>May</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>293</fpage>
            <page-range>293-304</page-range>
            <pub-id pub-id-type="pmid">29991937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollheimer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Halilbasic</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fickert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Trauner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of primary sclerosing cholangitis.</article-title>
            <source>Best Pract Res Clin Gastroenterol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>727</fpage>
            <page-range>727-39</page-range>
            <pub-id pub-id-type="pmid">22117638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Mahony</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Vierling</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Etiopathogenesis of primary sclerosing cholangitis.</article-title>
            <source>Semin Liver Dis</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-21</page-range>
            <pub-id pub-id-type="pmid">16496229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lalor</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Salmi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jalkanen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.</article-title>
            <source>Lancet</source>
            <year>2002</year>
            <month>Jan</month>
            <day>12</day>
            <volume>359</volume>
            <issue>9301</issue>
            <fpage>150</fpage>
            <page-range>150-7</page-range>
            <pub-id pub-id-type="pmid">11809275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludwig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barham</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>LaRusso</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Elveback</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Wiesner</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>McCall</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.</article-title>
            <source>Hepatology</source>
            <year>1981</year>
            <season>Nov-Dec</season>
            <volume>1</volume>
            <issue>6</issue>
            <fpage>632</fpage>
            <page-range>632-40</page-range>
            <pub-id pub-id-type="pmid">7308996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheuer</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>1998</year>
            <month>Feb</month>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-83</page-range>
            <pub-id pub-id-type="pmid">9473003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burak</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Is there a role for liver biopsy in primary sclerosing cholangitis?</article-title>
            <source>Am J Gastroenterol</source>
            <year>2003</year>
            <month>May</month>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>1155</fpage>
            <page-range>1155-8</page-range>
            <pub-id pub-id-type="pmid">12809842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <collab>European Association for the Study of the Liver</collab>
            <article-title>EASL Clinical Practice Guidelines: management of cholestatic liver diseases.</article-title>
            <source>J Hepatol</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>237</fpage>
            <page-range>237-67</page-range>
            <pub-id pub-id-type="pmid">19501929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bj&#x000f6;rnsson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boberg</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Cullen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clausen</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Fausa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schrumpf</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.</article-title>
            <source>Gut</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>731</fpage>
            <page-range>731-5</page-range>
            <pub-id pub-id-type="pmid">12377815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Angulo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maor-Kendler</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Small-duct primary sclerosing cholangitis: a long-term follow-up study.</article-title>
            <source>Hepatology</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>1494</fpage>
            <page-range>1494-500</page-range>
            <pub-id pub-id-type="pmid">12029635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gidwaney</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Pawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis and clinical spectrum of primary sclerosing cholangitis.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Apr</month>
            <day>14</day>
            <volume>23</volume>
            <issue>14</issue>
            <fpage>2459</fpage>
            <page-range>2459-2469</page-range>
            <pub-id pub-id-type="pmid">28465630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Apr</month>
            <day>06</day>
            <volume>332</volume>
            <issue>14</issue>
            <fpage>924</fpage>
            <page-range>924-33</page-range>
            <pub-id pub-id-type="pmid">7877651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendes</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Jorgensen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Katzmann</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Smyrk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Donlinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>101</volume>
            <issue>9</issue>
            <fpage>2070</fpage>
            <page-range>2070-5</page-range>
            <pub-id pub-id-type="pmid">16879434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sasahira</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsujino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Toda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Isayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Omata</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Serum IgG4 concentrations in pancreatic and biliary diseases.</article-title>
            <source>Clin Chim Acta</source>
            <year>2006</year>
            <month>May</month>
            <volume>367</volume>
            <issue>1-2</issue>
            <fpage>181</fpage>
            <page-range>181-4</page-range>
            <pub-id pub-id-type="pmid">16426597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Kowdley</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>ME</given-names>
              </name>
              <collab>American College of Gastroenterology</collab>
            </person-group>
            <article-title>ACG Clinical Guideline: Primary Sclerosing Cholangitis.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2015</year>
            <month>May</month>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>646</fpage>
            <page-range>646-59; quiz 660</page-range>
            <pub-id pub-id-type="pmid">25869391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fevery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kalloo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nagorney</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Boberg</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Shneider</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gores</surname>
                <given-names>GJ</given-names>
              </name>
              <collab>American Association for the Study of Liver Diseases</collab>
            </person-group>
            <article-title>Diagnosis and management of primary sclerosing cholangitis.</article-title>
            <source>Hepatology</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>660</fpage>
            <page-range>660-78</page-range>
            <pub-id pub-id-type="pmid">20101749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dave</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elmunzer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dwamena</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.</article-title>
            <source>Radiology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>256</volume>
            <issue>2</issue>
            <fpage>387</fpage>
            <page-range>387-96</page-range>
            <pub-id pub-id-type="pmid">20656832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lindor</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Primary sclerosing cholangitis: overview and update.</article-title>
            <source>Nat Rev Gastroenterol Hepatol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>7</volume>
            <issue>11</issue>
            <fpage>611</fpage>
            <page-range>611-9</page-range>
            <pub-id pub-id-type="pmid">20938459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soetikno</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Heidenreich</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>MO</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-54</page-range>
            <pub-id pub-id-type="pmid">12085034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Funiciello</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Belloli</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>[Problems of anesthesia and resuscitation in the surgical treatment of aortic coarctation in the first year of life].</article-title>
            <source>Acta Anaesthesiol</source>
            <year>1970</year>
            <season>Nov-Dec</season>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>777</fpage>
            <page-range>777-87</page-range>
            <pub-id pub-id-type="pmid">5538137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Medical approaches to primary sclerosing cholangitis.</article-title>
            <source>Semin Liver Dis</source>
            <year>1991</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-63</page-range>
            <pub-id pub-id-type="pmid">2047891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26964.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herlong</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Recker</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Maddrey</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D.</article-title>
            <source>Gastroenterology</source>
            <year>1982</year>
            <month>Jul</month>
            <volume>83</volume>
            <issue>1 Pt 1</issue>
            <fpage>103</fpage>
            <page-range>103-8</page-range>
            <pub-id pub-id-type="pmid">6978827</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
